CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

The fresh funding brings CroíValve's total raised, including grant financing, to $43m as it accelerates trials for its minimally invasive heart valve device.